Triparna Sen: Advances in lung cancer basic and translational research in 2025
Triparna Sen, Associate Professor at Icahn School of Medicine at Mount Sinai, shared a post on X:
“Excited to share our new paper from the IASLC Basic and Translational Science Committee: Advances in lung cancer basic and translational research in 2025.
This paper is the result of incredible teamwork from a truly global and diverse group of scientists. I had a lot of fun putting this together.
Grateful for the visionary leadership of Drs. Ming Tsao, Dr. Celine Mascoux, and I am honored to serve as a co-first author alongside some amazing colleagues.
The review covers key developments in NSCLC, including:
Molecular risk factors and tumorigenesis
Tumor heterogeneity and phenotypic plasticity
Metabolic reprogramming
Immunobiology and the tumor microenvironment
Microbiome
This is the first of many such collaborative efforts from the Basic and Translational Science Committee. The energy, commitment, and synergy in this group is truly inspiring.”
Title: Advances in lung cancer basic and translational research in 2025 – Overview and perspectives focusing on non-small cell lung cancer
Authors: Celine Mascaux, Triparna Sen, Montse Sanchez-Cespedes, Sandra Ortiz-Cuaran, Yohan Bossé, Floris Dammeijer, Milena Cavic, Martin P Barr, Surein Arulananda, Ricardo Armisen, Alice H Berger, Fabrizio Bianchi, David P Carbone, Ferdinando Cerciello, William W Lockwood, Tetsuya Mitsudomi, Shuta Ohara, Katerina Politi, Sida Qin, Laila C Roisman, Robert Samstein, Ferdinandos Skoulidis, Aaron C Tan, Anish Thomas, Jianjun Zhang, Murry W Wynes, Thomas John, Ming Sound Tsao
Read the Full Article.
More posts featuring Triparna Sen on OncoDaily.
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023